Ipca Laboratories Ltd.

1,561.3

0.5 (0%)growUp

As on March 13, 2026
SectorHealthcare
IndustryPharmaceuticals & Biotechnology
Basic IndustryPharmaceuticals
Market Cap39,584 Cr
P/E Ratio53.7
Dividend Yield0.26 %
Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock_ipo_icon.webpUnlock Stock of the Month

T&C*

Company Information


Market Insights
Open1,567
High1,576.7
NSE SymbolIPCALAB
Close1,561.3
Low1,537.4
BSE Symbol524494
Previous Years High/Low
1 Year High1,595
3 Year High1,755.9
5 Year High1,755.9
1 Year Low1,168.2
3 Year Low669.8
5 Year Low669.8

Technicals


IndicatorsValueSignal
5-DMA1,529.96Bullish
10-DMA1,516.22Bullish
20-DMA1,503.74Bullish
50-DMA1,480.65Bullish
100-DMA1,434.55Bullish
200-DMA1,410.55Bullish

Historical Performance


1 Year
20.2%
3 Years
96.6%
5 Years
59.9%
10 Years
477%

Shareholding Pattern


Values Analysis


Loading chart...

Profit & Loss

Below figures are in Rs. Crores


ParticularsMar-2025Mar-2024Mar-2023Mar-2022Mar-2021
Net Sales88,96876,62462,04357,96753,949
Total Expenditure72,26363,98453,01045,39139,137
Other Income1,5131,8441,5181,2171,292
Operating Profit18,21814,48410,55013,79316,104
Interest8781,408482112123
Depreciation3,9783,5722,6162,3242,092
Profit Before Tax11,3118,4277,45311,35713,890
Consolidated Net Profit7,3775,4734,7138,84111,400
Adjusted EPS2922193545
Compounded Sales Growth
10 Years:23.1
5 Years:14
3 Years:8.9
TTM:3
Compounded Profit Growth
10 Years:23.7
5 Years:4
3 Years:-3.6
TTM:6.2
Stock Price CAGR
10 Years:19.1
5 Years:9.8
3 Years:25.9
TTM:20.2
Return on Equity
10 Years:3.7
5 Years:44.9
3 Years:18.6
last year:29.1

Quarterly Results

Below figures are in Rs. Crores


ParticularsSep-2024Dec-2024Mar-2025Jul-2025Sep-2025
Sales1,70,7541,35,9361,28,5521,22,1891,05,161
Expenses63,04256,55752,45745,45934,856
Operating Profit1,07,71279,37976,09676,73070,304
OPM %63%58%59%63%67%
Other Income33,91231,75927,33324,87918,947
Interest77,78058,58459,24862,13753,713
Depreciation2,3451,6811,3851,2771,221
Profit Before Tax61,49850,87342,79638,19534,318
Tax %25%25%26%29%35%
Net Profit46,14938,15131,85727,29622,446
EPS in Rs8369585042

Balance Sheet

Below figures are in Rs. Crores


ParticularsMar-2025Mar-2024Mar-2023Mar-2022Mar-2021
Share Capital254254254254254
Total Reserves69,20463,05258,16654,39546,763
Long-Term Borrowings---------------
Total Non-Current Liabilities9,69110,1449,0176,1391,897
Other Current Liabilities7,2557,3264,8814,2052,045
Short Term Borrowings4,9525,5926,6183,6781,766
Total Liabilities1,17,4361,10,97086,22976,21560,664
Capital Work in Progress6,1623,2361,2222,9391,837
Long Term Loans & Advances3,1733,1562,2961,6961,856
Currents Investments7,6345,5843,2337,1933,938
Short Term Loans and Advances3,0491,9751,5562,0181,932
Total Current Assets59,67055,35551,89344,46734,370
Total Assets1,17,4361,10,97086,22976,21560,664
Adjusted Book Value274250230215185
0%
Positive
(80 to 100)
Neutral
(60 to 79)
Negative
(0 to 59)
  • The stock has a high PE of 53.7, indicating expensive valuation or elevated growth expectations.
  • Over the last three years, the stock delivered a strong 3-year price CAGR of 25.9%, indicating sustained price appreciation.
  • The stock carries a low beta of 0.6, suggesting lower volatility than the broader market.
  • In the last financial year, the company reported an EBITDA of ₹18218 million, reflecting positive operating performance.
  • In the previous financial year, the company generated revenue of ₹88968 million, indicating a large and established business.

Investment Calculator


Investment Amount:

Investment Amount: ₹ 1000000
Current Value: ₹ 1184867.6
No. of Shares: 759 (Approx)
Performance:18.5%
P/L: ₹184867.6
NIFTY Performance: 3.4%
1 day Top Gainers
SymbolChange%
LTTS3430.1(10%)
ACMESOLAR255.61(7%)
IFCI57.21(6%)
AIIL474.8(6%)
CHOLAHLDNG1553.9(5%)
1 Day Top Losers
SymbolChange%
CRAFTSMAN6674(-9%)
CEATLTD3470.5(-9%)
KPRMILL839.2(-8%)
LT3439(-8%)
AMBER6446(-7%)
ATGL565.9(-7%)
MRPL178.14(-7%)
PCBL253.2(-7%)

Top Performing Stocks from the same sector


Onesource Specialty Pharma Ltd.

25.8%

1491.2

1 Month Performance

Venus Remedies Ltd.

21.2%

894.45

1 Month Performance

Sakar Healthcare Ltd.

16.1%

518.75

1 Month Performance

Natco Pharma Ltd.

16%

955.85

1 Month Performance

Aurobindo Pharma Ltd.

13.2%

1296.5

1 Month Performance

JB Chemicals & Pharmaceuticals Ltd.

12.2%

2121.8

1 Month Performance

SMS Pharmaceuticals Ltd.

9.4%

368.75

1 Month Performance

Glenmark Pharmaceuticals Ltd.

8.7%

2170.7

1 Month Performance

Get Your Portfolio Reviewed

Stock of the Month
Stock of the Month